US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

110.50

-0.0338-0.03%

Post-market: 110.500.00000.00%19:30 EDT

Volume:108.64K

Turnover:12.04M

Market Cap:1.00B

PE:89.54

High:111.36

Open:110.76

Low:110.19

Close:110.53

52wk High:118.00

52wk Low:85.91

Shares:9.09M

Float Shares:9.09M

Volume Ratio:0.54

T/O Rate:1.20%

Dividend:2.18

Dividend Rate:1.97%

EPS(TTM):1.23

EPS(LYR):0.7765

ROE:--

ROA:--

PB:--

PE(LYR):142.31

Loading ...

Overview Company News Filings

Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks

Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)

Novartis Might Need More Deals to Deliver Growth Ambitions

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

AlzeCure Pharma to Present at Aktiedagen Event in Stockholm

Novartis's Latest Trial Setback Sinks Stock

Novartis Genetic Muscle Disorder Drug Fails Phase 3 Trial; Shares Drop Pre-Bell

MT Newswires Live

Novo Nordisk (0QIU) Receives a Hold from Barclays

United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday

Benzinga Earnings

Merck KGaA (0O14) Gets a Hold from Barclays

U.S. Research Roundup-Fedex Freight Holding Company, PDF Solutions, Robinhood Markets

Novartis's Latest Trial Failure is Second Pipeline Setback in a Row

Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

Yen advances to six-month high, chip stocks rise

Nicholas Reynolds / Bloomberg

Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) Hit by Another Heart Drug Setback

European Equities Remain Flat as Energy Gains Offset by Pharma Slump

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

Novartis AG Falls Monday, Underperforms Market

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/PPH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":110.5,"timestamp":1789588800000,"preClose":110.5338,"halted":0,"volume":108644,"hourTrading":{"tag":"盘后","latestPrice":110.5,"preClose":110.5,"latestTime":"19:30 EDT","volume":55,"amount":6084.72,"timestamp":1789601405786,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0003057888175381592,"floatShares":9088138,"shares":9088138,"eps":1.234146,"marketStatus":"Not Yet Opened","change":-0.0338,"latestTime":"09-16 16:00:00 EDT","open":110.76,"high":111.36,"low":110.19,"amount":12036387.37204,"amplitude":0.010585,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":110.5338,"sharesOutstanding":11938138,"nav":110.59843,"aum":994073948.99,"dividendRate":0.01971,"bidAskSpread":0.000395,"preHourTrading":{"tag":"盘前","latestPrice":109.7,"preClose":110.5338,"latestTime":"08:17 EDT","volume":1,"amount":109.7,"timestamp":1789561063190,"change":-0.8338,"changeRate":-0.007543,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":110.5,"preClose":110.5,"latestTime":"19:30 EDT","volume":55,"amount":6084.72,"timestamp":1789601405786,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.540328,"impliedVol":0.2308,"impliedVolPercentile":0.8406},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":9088138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":0.540328,"shares":9088138,"dividePrice":2.1779,"high":111.36,"amplitude":0.010585,"preClose":110.5338,"low":110.19,"week52Low":85.9086,"pbRate":"--","week52High":118,"institutionHeld":0,"latestPrice":110.5,"eps":1.234146,"divideRate":0.01971,"volume":108644,"delay":0,"ttmEps":1.234146,"open":110.76,"prevYearClose":103.17,"prevWeekClose":109.44,"prevMonthClose":113.08,"prevQuarterClose":109.35,"fiveDayClose":110.12,"twentyDayClose":113.2,"sixtyDayClose":103.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2026-07-01","symbol":"PPH","amount":0.6248,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-01","defaultRemindTime":1782912600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-07-01","currency":"USD","dateTimestamp":1782878400000,"payDate":"2026-07-07"},{"date":"2026-04-01","symbol":"PPH","amount":0.8441,"announcedDate":"2026-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-01","defaultRemindTime":1775050200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-07","payableDate":"2026-04-01","currency":"USD","dateTimestamp":1775016000000,"payDate":"2026-04-07"},{"date":"2025-12-29","symbol":"PPH","amount":0.3106,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-31"},{"date":"2025-10-01","symbol":"PPH","amount":0.3931,"announcedDate":"2025-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-01","defaultRemindTime":1759325400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-06","payableDate":"2025-10-01","currency":"USD","dateTimestamp":1759291200000,"payDate":"2025-10-06"},{"date":"2025-07-01","symbol":"PPH","amount":0.6069,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-01","defaultRemindTime":1751376600000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-07-01","currency":"USD","dateTimestamp":1751342400000,"payDate":"2025-07-07"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-03","recordDate":"2016-10-05","paymentDate":"2016-10-07","value":0.2148,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.1449,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.4651,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.304,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-06","value":0.221,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125754221","title":"Pharmaceutical Giant's Shares Plunge Nearly 10% Following Triple Clinical Trial Setbacks","url":"https://stock-news.laohu8.com/highlight/detail?id=1125754221","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125754221?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:00","pubTimestamp":1788858037,"startTime":"0","endTime":"0","summary":"Swiss pharmaceutical heavyweight Novartis faced a turbulent trading session on Tuesday as its shares tumbled sharply following the disclosure that its experimental drug for muscular dystrophy,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDTX","IE0009355771.USD","LU0320765489.SGD","BMED","IE00BFTCPJ56.SGD","PPH","IBBQ","BK4578","LU0211331839.USD","LU0208291251.USD","MEDX","BK4007","LU0070302665.USD","IE00B4R5TH58.HKD","NVS","PSYK","IE00BJT1NW94.SGD","BK4532","IBBJ","BK4585","BK4588","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665325786","title":"Market Chatter: Novo Nordisk Halts Two More Ziltivekimab Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325786","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665325786?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:57","pubTimestamp":1788857878,"startTime":"0","endTime":"0","summary":"Novo Nordisk  has stopped two additional trials of its experimental cardiovascular drug, ziltivekimab, after an independent committee found a low chance they would produce a different result from an earlier failed study, Reuters reported Monday.The trials, which tested the drug in heart failure patients, will end early, the company told MT Newswires. It added that patients will continue through to their 3-months follow-up as already planned.Novo said its trial testing ziltivekimab in an acute setting following a heart attack will continue as planned with results expected in H1 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LU0154236417.USD","NVOH","OZEM","NVOX","BK4585","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD","THNR","IE00BKVL7J92.USD","NVO","PPH","BK4588","LU1093756325.SGD","BK4599","NVOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665332552","title":"Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Merck & Company (MRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665332552","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665332552?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:30","pubTimestamp":1788856210,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on Sanofi (SNYNF) and Merck & Company (MRK) with neutral ratings, indicating that the experts are neithe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-sanofi-othersnynf-and-merck-company-mrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4588","LU1974910355.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0070302665.USD","IE00BFTCPJ56.SGD","LU1934455863.HKD","BMED","LU0006306889.USD","LU1061106388.HKD","LU1037948541.HKD","LU0477156953.USD","SG9999013999.USD","IE00BLSP4239.USD","LU0234572021.USD","LU0130517989.USD","LU0130102774.USD","LU2433249047.HKD","LU2361045086.USD","LU1430594728.SGD","SG9999014542.SGD","SG9999001440.SGD","SG9999015358.SGD","LU1934455194.USD","LU0122379950.USD","LU2491050154.USD","BK4559","LU1066051498.USD","LU0965509283.SGD","LU1989772840.SGD","FHLC","LU1162221912.USD","SG9999015341.SGD","LU0965509101.SGD","LU2361044949.HKD","LU0432979614.USD","LU1035773651.USD","LU1116320737.USD","SG9999014559.SGD","LU0289739699.SGD","BK4550","LU0868494708.USD","LU1093756325.SGD","LU2106854487.HKD","IE00BJT1NW94.SGD","LU2125154778.USD","LU1057294990.SGD","LU1093756168.USD","LU0266013472.USD","LU1699723380.USD","IE00BSNM7G36.USD","LU2023250843.SGD","LU0648001328.SGD","LU1023059063.AUD","IHE","IE00B2B36J28.USD","LU0203347892.USD","LU0320765489.SGD","SG9999014575.USD","LU1571399168.USD","IE00B1BXHZ80.USD","IXJ","LU1066051811.HKD","LU1585245621.USD","LU0098860793.USD","LU0106261372.USD","LU0868494617.USD","LU2491049909.HKD","LU2125154935.USD","SG9999001176.USD","SG9999002224.SGD","SG9999014567.USD","LU1989771016.USD","LU1934455277.USD","IE00BBT3K403.USD","PPH","LU2324357040.USD","LU0861579265.USD","LU1037948897.HKD","IE000M9KFDE8.USD","LU1941712264.USD","LU1116320901.HKD","LU2023250504.SGD","LU0265550946.USD","BK4585","IE00BN8TJ469.HKD","LU0942090050.USD","PAWZ","LU0859254822.USD","LU0124676726.USD","LU1917777945.USD","LU1069347547.HKD","LU2461242641.AUD","SG9999002232.USD","LU2112291526.USD","LU0265550359.USD","BK4516","LU0689626769.HKD","LU0208291251.USD","IE0009355771.USD","LU0211331839.USD","LU1923622614.USD","LU0203345920.USD","LU1989772923.USD","JDOC","FTXH","LU0320765646.SGD","LU1032466523.USD","IYH","LU2089984988.USD","SG9999001176.SGD","LU2360032135.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","SGXZ57979304.SGD","LU2357627491.SGD","MRK","RXL","LU1929549753.HKD","LU2125909247.SGD","IE00BJJMRZ35.SGD","LU1066051225.USD","BK4007","LU2361044865.SGD","LU0980610538.SGD","TRUH","LU0823416689.USD","BK4534","LU1983299246.USD","HRTS","LU1291159041.SGD","LU0965508806.USD","SNYNF","GDOC","LU1941712348.USD","IE0002141913.USD","LU0985320562.USD","LU2468319806.SGD","VHT","LU0238689110.USD","LU2125909593.SGD","LU0965509010.AUD","LU1201861249.SGD","LU2491050071.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323400","title":"Novartis Might Need More Deals to Deliver Growth Ambitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323400?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:17","pubTimestamp":1788855420,"startTime":"0","endTime":"0","summary":"0817 GMT - Novartis's latest clinical-trial failure suggests the company might need more dealmaking to deliver on its ambition for steady growth beyond 2030, Jefferies analysts say in a research note. The Swiss drugmaker maintained its 2025-30 sales guidance as it said its neuromuscular drug del-desiran missed the main goal in a late-stage study. However, no comment was provided on the ambition to grow by mid-single percentage digits beyond 2030, the analysts say. Even with the recent success of a new multiple-sclerosis pill, it will be challenging to get confidence on the company's growth for the 2030s without del-desiran and del-brax, two drugs Novartis acquired from Avidity Biosciences, Jefferies says. As a result, dealmaking will likely remain part of Novartis's story, the analysts add. Shares fall 10%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","IE0009355771.USD","NVS","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","MEDX","IE0002141913.USD","PPH","LU0211331839.USD","BK4588","BK4585","LU0070302665.USD","BK4007","IE00BJJMRZ35.SGD","LU0208291251.USD","IE00B4R5TH58.HKD","BK4532","BK4578","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532340","title":"Why the Dow is Being Dragged Down by a Swiss Company's Bad News","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532340?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:15","pubTimestamp":1788855300,"startTime":"0","endTime":"0","summary":"Bad news from Swiss pharmaceutical giant Novartis was weighing on the Dow on Tuesday.Investors returning from the Labor Day break could be forgiven for wondering if their eyes were deceiving them, but","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","AMGN","BK4007","LU1061106388.HKD","BK4566","IE00B4R5TH58.HKD","LU0208291251.USD","NVS","IE00BFTCPJ56.SGD","BK4585","MEDX","LU1023059063.AUD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4532","LU0058720904.USD","LU2468319806.SGD","IBB","LU0070302665.USD","BK4533","LU0122379950.USD","IE00B2B36J28.USD","BK4139","NAMS","LU0868494617.USD","LU1983299246.USD","BK4588","LU2112291526.USD","IE0002141913.USD","LU2242652126.USD","BBH","IBBQ","BK4581","IE0009355771.USD","LU0211331839.USD","LU1057294990.SGD","LU1571399168.USD","PJP","PPH","LU0289739699.SGD","SG9999001440.SGD","LU0320765992.SGD","BK4534","LU2089984988.USD","PBE","LU0109394709.USD","BK4578","BK4599","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323952","title":"AlzeCure Pharma to Present at Aktiedagen Event in Stockholm","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323952","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323952?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:03","pubTimestamp":1788854584,"startTime":"0","endTime":"0","summary":"AlzeCure Pharma to present at Aktiedagen event in StockholmAlzeCure will present at Aktiespararna’s Aktiedagen in Stockholm on Sept. 15.CEO Martin Jnsson is scheduled to speak at 16:25 CEST at Birger ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL83QQ0r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0001KFT4U8.USD","IXJ","LU2756315664.SGD","LU0109391861.USD","IE00BK4W5M84.HKD","LU0471298694.HKD","SG9999015986.USD","IE00BFTCPJ56.SGD","LU2456880835.USD","LU2552382058.USD","LU2211815571.USD","LU2746668461.USD","LU1720051017.SGD","LU0158827948.USD","LU2237443549.SGD","LU0238689110.USD","LU0256863811.USD","LU1023059063.AUD","JDOC","LU2896262040.SGD","SG9999015978.USD","LU2237443382.USD","IE00BJT1NW94.SGD","LU2089984988.USD","MEDI","TMED","LU0823434740.USD","LU1868837136.USD","SGXZ51526630.SGD","LU2471134952.CNY","LU0964807845.USD","LU0471298777.SGD","IE00BJLML261.HKD","LU2168564149.EUR","LU0353189763.USD","LU0316494557.USD","LU1691799644.USD","LU2063271972.USD","LU2028103732.USD","LU0823416689.USD","RXL","GDOC","LU0097036916.USD","LU2461242641.AUD","LU0466842654.USD","LU2108987350.USD","LU0432979614.USD","LU2491050154.USD","LU0203202063.USD","LU2552382132.HKD","SG9999015952.SGD","LU1868837300.USD","LLY","LLYZ","LU0109394709.USD","LU1712237335.SGD","LU2112291526.USD","SGXZ57979304.SGD","LU0320765992.SGD","LU0353189680.USD","LU1988902786.USD","LU2357305700.SGD","VHT","IE00B4R5TH58.HKD","LLII","LU0683600562.USD","IHE","THNR","GB00BDT5M118.USD","LU0158827781.USD","LU0320765059.SGD","IE00BKPKM429.USD","IYH","LU2264538146.SGD","LU2271345857.HKD","MHIP","LU1983299246.USD","BK4581","IE0004445239.USD","LU2750360641.GBP","LU2213496289.HKD","BK4007","LU0889565916.HKD","IE00BJJMRX11.SGD","LU0133085943.USD","LU1551013342.USD","LU1267930730.SGD","LU1989771016.USD","CURE","LU0061475181.USD","LU1291159041.SGD","SG9999001176.SGD","SG9999014906.USD","IE00BJJMRZ35.SGD","LU1629891620.HKD","LU0820562030.AUD","WDNA","ILDR","LU0786609619.USD","LU0096364046.USD","LU2471134796.USD","IE00BK4W5L77.USD","LU0225283273.USD","LU2168564065.EUR","LU0345770993.USD","IE00BKDWB100.SGD","SG9999017495.SGD","ELIS","LU1069344957.HKD","PPH","LU2237443895.HKD","LU0210536198.USD","LU2471134879.HKD","LU1917777945.USD","LU1064131342.USD","LU1804176565.USD","CANC","IE0005OL40V9.USD","LU0106261372.USD","FHLC","LU0882574055.USD","LU1035775433.USD","LU1145028129.USD","LU2023251221.USD","LU2237438978.USD","LU2106854487.HKD","LU0354030511.USD","MEDX","LU2750360997.AUD","LU2168564495.EUR","LU2237443622.USD","LU2324357040.USD","HRTS","IE00B2B36J28.USD","LU0640476718.USD","SG9999001176.USD","LU2468319806.SGD","LU1814569148.SGD","BK4599","LU2602419157.SGD","OZEM","LU0006306889.USD","LU2089284900.SGD","LU0114720955.EUR","LU0203201768.USD","TRUH","LU0198837287.USD","IE00B7KXQ091.USD","LU1548497426.USD","LU2491049909.HKD","LU1979441026.SGD","LU1127390331.HKD","LU1232071149.USD","IE00BN29S564.USD","IE00BFSS7M15.SGD","LU0456855351.SGD","LU1093756168.USD","LU0708995401.HKD","LU0385154629.USD","LU0174119429.USD","LU2168563687.JPY","LU2236285917.USD","FTXH","LU0256863902.USD","LU0672654240.SGD","SG9999015945.SGD","LU2023250504.SGD","LU2361044949.HKD","LU0094547139.USD","LU2168564222.USD","IE00B1BXHZ80.USD","LU2756315318.SGD","LU1280957306.USD","SG9999018865.SGD","SGXZ31699556.SGD","LU1868836591.USD","LU2265009873.SGD","ELIL","LU0234572021.USD","BK4534","LU1366192091.USD","LU0122379950.USD","LU0289739699.SGD","LU0266013472.USD","LU2462591350.SGD","LU2746668974.SGD","SG9999014880.SGD","LU0787776722.HKD","LU2360106947.USD","LU1061106388.HKD","SG9999018857.SGD","LU0689472784.USD","LU0354030438.USD","LU2237443465.HKD","LU2087625088.SGD","LU2552382215.SGD","LU1623119135.USD","LU0323591593.USD","XLV","SG9999013999.USD","LU2417539215.USD","LU2491050071.SGD","IE00B775H168.HKD","LU1551013425.SGD","LU1093756325.SGD","LU1323610961.USD","LU2023250330.USD","PJP","LU1720051108.HKD","LU0820561909.HKD","IE00BFSS8Q28.SGD","LU1868836757.USD","IE00BJJMRY28.SGD","LU2361044865.SGD","IE00BWXC8680.SGD","AGNG","LU0345770308.USD","LU2111349929.HKD","LU2089283258.USD","LU0058720904.USD","LU2361045086.USD","LU1057294990.SGD","LU0079474960.USD","BK4533","IE0002141913.USD","LU0943347566.SGD","IE0009355771.USD","IE0004445015.USD","LU0823434583.USD","LU0882574139.USD","SGXZ81514606.USD","SG9999014914.USD","BK4585","LLYX","LU0417517546.SGD","SG9999014898.SGD","IE00B4JS1V06.HKD","LU1868836914.USD","LU2462157665.USD","LU2237443978.SGD","LU2471134523.USD","LU0820561818.USD","IE00B1XK9C88.USD","BK4588","LU1974910355.USD","SGXZ99366536.SGD","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323985","title":"Novartis's Latest Trial Setback Sinks Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323985","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323985?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:01","pubTimestamp":1788854460,"startTime":"0","endTime":"0","summary":"Novartis shares plunged after the Swiss drugmaker said an experimental neuromuscular medicine missed the primary goal in a late-stage clinical trial, the latest blow to its efforts to find new growth ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0009355771.USD","NVS","LU0320765489.SGD","BK4585","IE00BJT1NW94.SGD","BK4007","LU0211331839.USD","LU0208291251.USD","BK4588","BK4532","PPH","BK4578","IE0002141913.USD","LU0070302665.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665323534","title":"Novartis Genetic Muscle Disorder Drug Fails Phase 3 Trial; Shares Drop Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2665323534","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665323534?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:58","pubTimestamp":1788854332,"startTime":"0","endTime":"0","summary":"Novartis  said Tuesday its phase 3 Harbor study evaluating delpacibart etedesiran in patients with myotonic dystrophy type 1 failed to meet its primary endpoint of video hand opening time.The drug candidate for the genetic muscular disorder displayed signs of clinical activity for its secondary endpoints measuring muscle strength, daily living activities, and mobility during the trial, the company said.The company is analyzing the full dataset to decide future development plans while maintaining its five-year annual sales growth target of 5% to 6% through 2030, Novartis said.Shares of the company were down by more than 13% in Tuesday premarket activity.Price: 138.80, Change: -21.19, Percent Change: -13.24","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NVS","BK4588","BK4007","PPH","LU0211331839.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","MEDX","IE0002141913.USD","BK4578","BK4532","LU0070302665.USD","BK4585","LU0208291251.USD","LU0320765489.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665328428","title":"Novo Nordisk (0QIU) Receives a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2665328428","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665328428?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:25","pubTimestamp":1788852330,"startTime":"0","endTime":"0","summary":"Barclays analyst James Gordon CFA maintained a Hold rating on Novo Nordisk today and set a price target of DKK300.00. According to TipRanks, Gordon...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novo-nordisk-0qiu-receives-a-hold-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OZEM","PPH","LU0154236417.USD","LU1093756168.USD","NVOH","NVOC","BK4532","BK4588","NVO","NVOX","BK4585","THNR","LU1093756325.SGD","BK4007","IE00BKVL7J92.USD","BK4599","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665402063","title":"United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2665402063","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665402063?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:11","pubTimestamp":1788851511,"startTime":"0","endTime":"0","summary":"Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey’s earnings expected.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/long-ideas/26/09/61650635/united-natural-foods-abm-industries-and-3-stocks-to-watch-heading-into-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FXG","RGLO","BK4082","UNFI","VGFPF","VOTE","IE00B2B36J28.USD","BK4007","BK4578","LU1878469433.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","PPH","ABM","LU0708995401.HKD","LU1267930730.SGD","LU0208291251.USD","LU0211331839.USD","IE0009354923.USD","LU0320765489.SGD","BK4585","BK4568","LU0320765059.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","FEBU","IE00BJJMRZ35.SGD","BK4532","LU0672654240.SGD","JOYT","NVS","BK4102","LU0109391861.USD","BK4588","MEDX","GXDW","DECU","CASY","BK4120","PMDE","BK4113","CODX","LU0070302665.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665097340","title":"Merck KGaA (0O14) Gets a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2665097340","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665097340?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:05","pubTimestamp":1788851124,"startTime":"0","endTime":"0","summary":"In a report released today, James Gordon CFA from Barclays maintained a Hold rating on Merck KGaA, with a price target of €150.00. According to Tip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/merck-kgaa-0o14-gets-a-hold-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/merck-kgaa-0o14-gets-a-hold-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1069347547.HKD","TRUH","LU2125909247.SGD","SG9999015341.SGD","PPH","RXL","LU1974910355.USD","LU1066051225.USD","LU2125154935.USD","BMED","SG9999001176.SGD","LU0868494617.USD","LU0289739699.SGD","LU0859254822.USD","LU2491050071.SGD","LU0098860793.USD","LU1066051811.HKD","LU2468319806.SGD","LU1057294990.SGD","LU1061106388.HKD","LU1023059063.AUD","LU2491049909.HKD","LU1585245621.USD","SG9999013999.USD","FTXH","HRTS","IYH","IE0002141913.USD","LU0965509010.AUD","LU0130102774.USD","LU2357627491.SGD","SG9999014542.SGD","IXJ","LU2324357040.USD","PAWZ","VHT","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK4534","LU0965508806.USD","MRK","JDOC","CFA","IHE","XLV","FHLC","GDOC","LU0823416689.USD","SG9999014567.USD","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665034015","title":"U.S. Research Roundup-Fedex Freight Holding Company, PDF Solutions, Robinhood Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2665034015","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665034015?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:01","pubTimestamp":1788850904,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Fedex Freight Holding Company, PDF Solutions, Robinhood MarketsSept 8 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500G3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSDD","SHAK","ONTO","VERA","FDS","SYM","PTON","ODFL","JBTM","APH","CHRW","SPCX","IRM","BHVN","EQIX","PSR","PATH","HOOD","ABBV","SLG","CDW","MTB","FDX","PDFS","FHLC","SNX","VRSK","DG","REAI","MANH","SPCF","HOOI","ADBE","SAIA","SECZ","ARWR","ABNB","SG","IQRA","ST","DLTR","MGY","MLM","FDXF","IYR","GPOR","PPH","VHT","MSTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665034034","title":"Novartis's Latest Trial Failure is Second Pipeline Setback in a Row","url":"https://stock-news.laohu8.com/highlight/detail?id=2665034034","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665034034?lang=en_us&edition=fundamental","pubTime":"2026-09-08 14:46","pubTimestamp":1788849960,"startTime":"0","endTime":"0","summary":"0646 GMT - Novartis just suffered its second major pipeline setback in the past week after a drug candidate it acquired through its recent $12 billion Avidity Biosciences deal failed in a late-stage study, Vontobel's Stefan Schneider says in a research note. News that experimental drug del-desiran missed the goal in a trial for neuromuscular disease myotonic dystrophy type 1 comes after the Swiss pharmaceutical company last week reported disappointing results for cardiovascular medicine pelacarsen. Vontobel had forecast annual peak sales from del-desiran at $3 billion, with a 50% chance of reaching them, and now removes this forecast from its model. As a result, Vontobel cuts its target price on Novartis stock to 125 Swiss francs from 128 francs. Novartis shares closed at 125.46 francs on Monday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","MEDX","BK4007","BK4578","IE00BJJMRZ35.SGD","LU0320765489.SGD","PPH","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4585","LU0211331839.USD","NVS","BK4588","LU0070302665.USD","LU0208291251.USD","IE0002141913.USD","IE00BJT1NW94.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665631001","title":"Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2665631001","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665631001?lang=en_us&edition=fundamental","pubTime":"2026-09-08 05:40","pubTimestamp":1788817216,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) has halted two trials testing if ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-halts-two-trials-testing-ziltivekimab-bloomberg-reports-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","NVO","LU0154236417.USD","LU1093756168.USD","BK4599","BK4532","BK4588","IE00BKVL7J92.USD","LU1093756325.SGD","THNR","NVOX","NVOH","NVOC","BK4007","OZEM","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376683","title":"Yen advances to six-month high, chip stocks rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376683","media":"Nicholas Reynolds / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376683?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:14","pubTimestamp":1788804840,"startTime":"0","endTime":"0","summary":"The yen extended Monday's advance to reach the strongest level since February, aided by rising expectations of a Bank of Japan interest-rate increase next week.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/highlight/stocks-asia-poised-edge-down-yen-focus?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["LU0208291251.USD","LU2458330243.SGD","LU0203345920.USD","LU0444973449.USD","LU1861219969.SGD","LU0198837287.USD","IE00BDCRKT87.USD","PPH","LU0320765059.SGD","IE00BLSP4452.SGD","LU0251132253.USD","LU0472753341.HKD","LU1064131342.USD","LU0342679015.USD","LU0476273544.USD","LU1935042215.USD","LU1244550577.SGD","IE00BYXW3230.USD","LU0211326755.USD","LU0211327993.USD","IE00B19Z3581.USD","LU2360106780.USD","LU2168564222.USD","LU0719512351.SGD","SG9999014880.SGD","IE00BK4W5L77.USD","TRUF","BK4533","LU0965509010.AUD","LU0345770308.USD","LU1989764664.SGD","SG9999015945.SGD","LU2106854487.HKD","IE000M9KFDE8.USD","LU2357627491.SGD","LU0215105999.USD","LU2087625088.SGD","LU0640476718.USD","LU2168563687.JPY","GB00B4QBRK32.GBP","LU0949170772.SGD","NVO","LU0965509283.SGD","SG9999000418.SGD","LU0661504455.SGD","LU2746668974.SGD","IYT","IE00BKDWB100.SGD","SG9999001424.SGD","SG9999018857.SGD","LU2896262040.SGD","LU0320765646.SGD","LU0238689110.USD","BK4532","IYG","LU1983260115.SGD","WNDR","LU0417517546.SGD","LU0353189763.USD","LU0234572021.USD","LU1280957306.USD","LU0868494708.USD","THNR","LU2326559502.SGD","LU0106261372.USD","LU0882574139.USD","LU2430703178.SGD","LU0345774391.USD","LU2237443895.HKD","IE0009356076.USD","LU2023251221.USD","LU0738911758.USD","LU0289961442.SGD","LU0964807845.USD","LU0552385451.USD","LU0859254822.USD","LU1119994496.HKD","LU2237957902.USD","LU2054465674.USD","LU1116320901.HKD","BK4534","IE0034235295.USD","LU0081259029.USD","LU2360107325.USD","LU1712237335.SGD","LU1037948541.HKD","LU1261432733.SGD","LU2237443382.USD","IGV","BK4588","LU0057025933.USD","BK4097","LU1852331112.SGD","LU0234570918.USD","LU0170899867.USD","LU2213496289.HKD","LU0127658192.USD","LU0211328371.USD","BK4503","LU1145028129.USD","LU1046421795.USD","SGXZ81514606.USD","LU2756315664.SGD","IYF","LU1366333091.USD","SG9999003800.SGD","LU2404859741.USD","LU1003077747.HKD","LU2237438978.USD","LU1267930730.SGD","LU2458330169.SGD","LU0787776722.HKD","IE00B1BXHZ80.USD","LU1363072403.SGD","BK4581","LU0211326839.USD","LU1548497426.USD","SG9999015952.SGD","LU1435385759.SGD","LU2381873111.SGD","LU1894683264.USD","LU0107464264.USD","IE00BJLML261.HKD","LU0158827948.USD","BK4585","LU1623119135.USD","LU1815336760.USD","LU0820562030.AUD","LU0957808578.USD","TDIV","SG9999015986.USD","IE00BFXG1179.USD","BK4022","LU2357305700.SGD","LU2250418816.HKD","FTXO","LU1935042991.SGD","LU1093756325.SGD","LU0353189680.USD","LU2430703251.USD","BK4599","IE0034235188.USD","LU0265550946.USD","LU1720051017.SGD","LU0980610538.SGD","IE00BZ1G4Q59.USD","LU0511384066.AUD","LU0942090050.USD","BK4554","ORCZ","LU1235294995.USD","BK4567","LU1934455277.USD","LU2242649171.HKD","BK4551","IE00B19Z9505.USD","NVOH","ORCX","BK4550","IE00BKVL7J92.USD","LU1629891620.HKD","LU1917777945.USD","IE00BMPRXR70.SGD","LU0545039389.USD","LU1674673428.USD","NVOX","IE00BZ199S13.USD","KBWB","BK4230","LU0553294199.USD","BK4536","LU0256863902.USD","LU0109391861.USD","LU0069063385.USD","LU0345769631.USD","IE00B7SZLL34.SGD","LU1037948897.HKD","ADBU","BK4543","UYG","LU1674673691.USD","LU1429558221.USD","LU1244550221.USD","IE00BFMHRM44.USD","LU0320765489.SGD","TPOR","ORCU","JPM","LU2746668461.USD","LU2089283258.USD","LU0048584097.USD","LU1803068979.SGD","LU2360032135.SGD","LU1093756168.USD","LU2237443978.SGD","BK4007","LU0861579265.USD","LU2552382215.SGD","LU0310799852.SGD","LU0943347566.SGD","ADBE","IE00BQXX3C00.GBP","LU2125154935.USD","BK4505","LU2317271919.USD","LU1489326972.SGD","LU1642822529.SGD","ADBG","GB00B4LPDJ14.GBP","SG9999002232.USD","LU0689472784.USD","OGIG","LU2462157665.USD","LU1815333072.USD","IE00B5949003.HKD","LU0792757196.USD","LU2237443549.SGD","SGXZ99366536.SGD","LU2097829019.USD","SG9999017495.SGD","LU0082616367.USD","LU2552382132.HKD","IE00BK4W5M84.HKD","LU0211331839.USD","IE00BHPRN162.USD","IE00B3S45H60.SGD","LU1914381329.SGD","LU0175139822.USD","LU0708995401.HKD","ORCL","IE00BJTD4V19.USD","LU2505996681.GBP","LU0976567544.SGD","IXG","LU0444971666.USD","LU0210536198.USD","LU2552382058.USD","LU1162221912.USD","IE00BQXX3D17.EUR","IE00B19Z3B42.SGD","LU0289739343.SGD","BK4516","BK4566","NVOC","LU1496350171.SGD","LU0820561818.USD","LU1551013425.SGD","LU1935043536.SGD","SG9999015978.USD","SG9999018865.SGD","LU0965509101.SGD","LU2210149790.SGD","LU1814569148.SGD","IE00BQXX3F31.USD","VFH","IE00B5TLWC47.USD","LU1069347547.HKD","LU0154236417.USD","LU0267386448.USD","UBRL","LU0642271901.SGD","LU1084165304.USD","LU0130102774.USD","IE00BYQQ9H92.USD","LU2023250330.USD","IE00BN8TJ469.HKD","LU2244417387.USD","BK4538","LU0149725797.USD","LU2168564149.EUR","LU1934455863.HKD","UBER","IE00BWXC8680.SGD","IE00BFXG0V08.USD","LU0820561909.HKD","LU2756315318.SGD","FDRV","LU1989772923.USD","LU2264538146.SGD","LU2505996509.AUD","SG9999011175.SGD","BK4023","SG9999014906.USD","JPMO","IE00B775SV38.USD","LU2860962120.EUR","LU1201861249.SGD","LU0348723411.USD","LU2168564495.EUR","LU0433182093.SGD","IE00BJTD4N35.SGD","LU0203347892.USD","LU0265550359.USD","SG9999002224.SGD","LU2543165471.USD","LU0187121727.USD","LU1670628061.USD","LU1989764748.USD","LU1935042488.USD","BK4528","ORAC","LU1720051108.HKD","LU1633808545.USD","LU1988902786.USD","LU1691799644.USD","SGXZ31699556.SGD","LU1496350502.SGD","LU0345774631.USD","BK4527","LU0068578508.USD","LU1316542783.SGD","LU1267930490.SGD","LU2211815571.USD","IE0002270589.USD","LU1989772840.SGD","LU0889565833.HKD","LU1934455194.USD","LU0985489474.SGD","LU0496365809.HKD","LU1670627923.USD","IE0034235303.USD","LU0006306889.USD","LU0070302665.USD","LU1935043023.USD","LU2404859667.USD","SORCLmain","LU0289960550.SGD","IE00BMPRXQ63.HKD","IE00BBT3K403.USD","SG9999014914.USD","LU1366192091.USD","BK4207","LU0109392836.USD","LU0672654240.SGD","LU0056508442.USD","LU1032466523.USD","IE00BMPRXN33.USD","JPO","LU2023250504.SGD","LU2089284900.SGD","LU1244550494.USD","LU1506573853.SGD","LU0690374615.EUR","TFNS","LU2456880835.USD","LU0557290698.USD","LU0683600562.USD","XLF","OZEM","LU1974910355.USD","LU0957791311.USD","LU0690374961.EUR","LU0256863811.USD","UBEW","LU0106831901.USD","LU2592432038.USD","LU1823568750.SGD","LU2430703095.HKD","LU2237957811.SGD","LU0868494617.USD","LU0323591593.USD","LU0648001328.SGD","ORCS","LU0157215616.USD","LU0345770993.USD","LU2237443622.USD","LU1778281490.HKD","SG9999014898.SGD","LU0965508806.USD","LU0345769128.USD","IE00BLSP4239.USD","LU0314104364.USD","LU1668664300.SGD","LU2417539215.USD","LU1035773651.USD","LU0878866978.SGD","LU0314106906.USD","BK4535","LU2237443465.HKD","LU0971096721.USD","FNCL","SGXZ51526630.SGD","IE00BDRTCR15.USD","LU2023250843.SGD","LU0889566641.SGD","LU2168564065.EUR","BK4592","LU1267930813.SGD","LU2236285917.USD","GB00BDT5M118.USD","LU2108987350.USD","LU2095319765.USD","LU2210150020.SGD","LU1551013342.USD","IE00B1XK9C88.USD","LU1894683348.USD","BK4504","IE0004445239.USD","LU1116320737.USD","LU1861214812.USD","LU2125154778.USD","LU0061474960.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665109773","title":"Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2665109773","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665109773?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:10","pubTimestamp":1788804610,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-step-young-phase-3-trial-met-its-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","BK4532","BK4588","LU0154236417.USD","BK4007","NVOX","LU1093756325.SGD","IE00BKVL7J92.USD","NVOH","IE00BZ1G4Q59.USD","PPH","NVOC","BK4585","THNR","OZEM","LU1093756168.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665862310","title":"Novo Nordisk (NVO) Hit by Another Heart Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2665862310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665862310?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:56","pubTimestamp":1788800218,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/novo-nordisk-nvo-hit-by-another-heart-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPH","BK4599","IE00BZ1G4Q59.USD","NVO","IE00BKVL7J92.USD","BK4532","BK4585","LU1093756325.SGD","NVOH","THNR","LU1093756168.USD","LU0154236417.USD","BK4007","NVOC","OZEM","NVOX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193693103","title":"European Equities Remain Flat as Energy Gains Offset by Pharma Slump","url":"https://stock-news.laohu8.com/highlight/detail?id=1193693103","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193693103?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:30","pubTimestamp":1788798644,"startTime":"0","endTime":"0","summary":"European markets closed Monday with little movement, as rising crude prices and a sharp decline in a major pharmaceutical firm counterbalanced each other. The benchmark Stoxx Europe 600 index...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UAE","DBEF","GIEQ","SEIE","ICOW","CGIE","PTIN","URTH","PDEV","PQIN","ESIM","PXJ","XES","GXUS","MFSI","LU0320765489.SGD","ERX","INOV","CEFA","EUDG","EPV","BK4534","OILK","EAFG","ICPY","IMAR","PXF","CVIE","HEFA","EFO","OIH","XEUR","BK4578","IOCT","IDEC","SPDW","YMAR","USOI","FDEV","HAWX","FIEE","BK4167","ITOL","OILU","BKCI","IDMY","ISDX","KOKU","USL","WEEI","JDVI","IJAN","JHMD","XW","BRIE","AIVI","BBIN","BK4570","IJUL","GSEU","NUDM","QBIF","ARLI","PIZ","MFDX","IEUR","IXUS","AFDM","VDE","RAYD","VEU","BK4504","OPPE","YSEP","FENI","EFA","DTAN","JPIN","DUG","WTIU","SPEU","FLEE","IMOM","BKIE","IQDF","PGRI","DFAX","RODE","IDMO","TOK","VOOV","DBO","TDI","SCHF","IE00BFTCPJ56.SGD","TLTD","DDWM","TILC","DRIP","OVF","SPXT","DEEF","SDOG","FDT","BINV","OEFA","IEO","VIDI","REFA","DIG","TPOR","BK4588","LU0070302665.USD","BK4007","PEJ","DMXF","BK4582","PIEQ","PPH","QBIV","EPIN","NBIE","BUFI","BK4581","IMTM","EFZ","IEV","DFAI","IMFL","ISWN","JULI","AVDE","LU0208291251.USD","EFAX","BAIV","YDEC","JIRE","BK4532","AVNM","GSIE","IFEB","RINT","RFEU","VNIE","OAIM","TACN","EWN","SSXU","UIVM","BUFY","IE00B4R5TH58.HKD","LU0211331839.USD","IE00B2B36J28.USD","QEFA","BWET","DFIC","OILT","PZIV","AVIV","IDEQ","XEML","FFDI","NVS","RODM","ISEP","UGA","DXIV","PPIE","GUSH","WCMG","IAPR","FTXN","VEFA","STXI","USE","FHIL","FSZ","CGXU","BBEU","GLBL","MEDX","RDMX","IFV","BNO","IVAL","TIIV","FINT","IDME","DMXU","IAUG","IDEV","BK4550","PXE","ACWX","DBE","FEDM","IBUF","IGGY","WCMI","VGK","GLOF","IE0009355771.USD","DINT","AVSD","DBC","DWMF","FEOE","IE00BJT1NW94.SGD","ENHI","MOTI","NIHI","QLVD","TLCI","IVSI","TXUE","FEZ","DRLL","FEP","HFXI","JANI","VEA","IXC","CGIC","IJUN","PTEU","IDUB","IFLR","UPV","BK4585","IEFA","TPIF","ILOW","IQLT","EURL","INTF","WWJD","IE00BJJMRZ35.SGD","EASG","IE0002141913.USD","APIE","CWI","IQSI","IMAY","TOUS","RFDI","XLEX","GSID","BK4020","DBEU","IDJN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317069","title":"Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317069?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:21","pubTimestamp":1788798066,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultrageny...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-intellia-therapeutics-ntla-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-merck-company-mrk-intellia-therapeutics-ntla-and-ultragenyx-pharmaceutical-rare-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1023059063.AUD","LU1116320901.HKD","LU1699723380.USD","LU0006306889.USD","LU0320765646.SGD","SG9999015358.SGD","LU2324357040.USD","LU2361044949.HKD","BK4588","LU1917777945.USD","LU1093756325.SGD","LU0058720904.USD","BK4550","LU1069347547.HKD","VHT","LU0689626769.HKD","LU1983299246.USD","SG9999001176.SGD","LU1989771016.USD","SG9999002224.SGD","LU0265550946.USD","LU1066051498.USD","SG9999015341.SGD","PAWZ","LU0124676726.USD","LU2361044865.SGD","NTLA","LU2089984988.USD","LU1430594728.SGD","LU1061106388.HKD","LU0965509010.AUD","LU1934455194.USD","SG9999013999.USD","LU2125154935.USD","SGXZ57979304.SGD","TRUH","IE00BLSP4239.USD","IE00BLSP4452.SGD","LU0648001328.SGD","BK4556","LU0965508806.USD","SG9999014567.USD","BK4535","LU0106261372.USD","LU0861579265.USD","SG9999014559.SGD","LU0868494617.USD","LU1934455277.USD","LU0859254822.USD","BK4533","IE0002141913.USD","LU0868494708.USD","MRK","IE0009355771.USD","LU0477156953.USD","LU1116320737.USD","LU1934455863.HKD","LU2491049909.HKD","SG9999001440.SGD","LU2023250504.SGD","LU1057294990.SGD","LU0289739699.SGD","LU0208291251.USD","LU1989772840.SGD","SG9999014575.USD","LU1941712264.USD","FTXH","LU2361045086.USD","GDOC","LU2125154778.USD","IE00BFTCPJ56.SGD","LU1861558580.USD","LU0942090050.USD","IE00BJJMRZ35.SGD","LU1929549753.HKD","LU2491050154.USD","LU2112291526.USD","LU1066051811.HKD","LU1989772923.USD","LU1585245621.USD","SG9999001176.USD","FHLC","BMED","LU1066053197.SGD","LU2491050071.SGD","LU0203347892.USD","LU0823416689.USD","RXL","LU2357627491.SGD","LU0432979614.USD","LU0980610538.SGD","LU2125909593.SGD","BK4559","IE00B1BXHZ80.USD","LU1162221912.USD","IYH","LU2023250843.SGD","LU2461242641.AUD","PPH","RARE","JDOC","LU0098860793.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU2433249047.HKD","LU0965509101.SGD","IHE","LU0122379950.USD","LU2360032135.SGD","LU1035773651.USD","LU0234572021.USD","LU0265550359.USD","IE00BSNM7G36.USD","LU0203345920.USD","LU1861559042.SGD","LU1974910355.USD","BK4007","LU0238689110.USD","LU0965509283.SGD","LU1066051225.USD","LU0320765489.SGD","LU1032466523.USD","BK4139","SG9999002232.USD","IE00B4R5TH58.HKD","LU0211331839.USD","LU1037948897.HKD","IE00BJT1NW94.SGD","LU1201861249.SGD","LU2468319806.SGD","LU0070302665.USD","SG9999014542.SGD","LU1571399168.USD","LU1291159041.SGD","LU1037948541.HKD","LU2125909247.SGD","IE00BN8TJ469.HKD","LU0130102774.USD","LU0266013472.USD","LU0985320562.USD","IXJ","LU1941712348.USD","BK4585","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU1093756168.USD","HRTS","LU1923622614.USD","LU0130517989.USD","BK4534","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317208","title":"Novartis AG Falls Monday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317208","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317208?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:15","pubTimestamp":1788797700,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novartis AG  dropped 3.2% to CHF125.46 Monday on what proved to be an overall unfavorable trading session for the stock market, with the Swiss Market Index SMI Index  falling 0.8% to 14,279.38.Novartis AG closed CHF7.22 short of its 52-week high of CHF132.68, which the company achieved on September 3, 2026.Trading volume was 3,077,526, compared to the 50-day average trading volume of 2,290,037.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","BK4007","BK4578","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","PPH","LU0208291251.USD","LU0211331839.USD","LU0320765489.SGD","BK4585","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4532","NVS","BK4588","MEDX","LU0070302665.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":9,"totalSize":241,"code":"91000000","status":"200"}]}}